Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN13971661Phase 4Completed
Phase 4 trial of polidocanol + urea in chronic kidney disease-associated pruritus (CKD-aP) (2 arms), sponsored by Portsmouth Hospitals University NHS Trust. Primary endpoint: Reduction in itch intensity. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN13971661.